They have to push through with the listing of NGIO. GNBT fell through with their listing and NGIO has all the components to succeed on that front and based on the information that has already been presented, there is no reason why NGIO can't be listed.
So, while this vaccine work is getting done, they need to get the listing completed once and for all for NGIO.
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links